Table 2:

Relative Enzymatic Activity of UGT1A1 Variants

Allele nameVariantRelative activityPotential impact on drug metabolismCPIC functional statuse
UGT1A1*1 None (promoter [TA]6TAA)100%aNormalNormal function
UGT1A1*6 p.Arg71Gly70%bSlowerDecreased function
UGT1A1*27 p.Pro229Gln

50% c

SlowerDecreased function
UGT1A1*28 Promoter (TA)7TAA65%aSlowerDecreased function
UGT1A1*36 Promoter (TA)5TAA130%aFasterIncreased function
UGT1A1*37 Promoter (TA)8TAA50%aSlowerDecreased function
UGT1A1*60 c.-3279T>G60%dSlowerNormal functionf

CPIC – Clinical Pharmacogenetics Implementation Consortium

a

Activity level from (35)

b

Activity level from (51)

c

Activity level from (56)

d

Activity level from (44)

e

Functional status from (57)

f

Functional status from (58)

From: Belinostat Therapy and UGT1A1 Genotype

Cover of Medical Genetics Summaries
Medical Genetics Summaries [Internet].
Pratt VM, Scott SA, Pirmohamed M, et al., editors.
Copyright Notice

All Medical Genetics Summaries content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license which permits copying, distribution, and adaptation of the work, provided the original work is properly cited and any changes from the original work are properly indicated. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.